Generation Bio Co. (GBIO)
NASDAQ: GBIO
· Real-Time Price · USD
0.39
-0.05 (-10.55%)
At close: Jun 09, 2025, 3:59 PM
Generation Bio Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| One Reportable Segment Revenue | 19.89M |
| One Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.83M | 8.66M | 9.18M | 9.52M | 10.43M | 13.38M | 11.64M | 12.97M | 12.87M | 13.08M | 11.48M | 10.12M | 9.79M | 9.1M | 9.67M | 8.19M | 6.9M | 7.97M | 5.66M | 4.31M | 4.64M | 3.43M | 2.89M | 3.1M | 2.76M |
| Selling, General, and Administrative Revenue Growth | +2.06% | -5.72% | -3.51% | -8.76% | -22.04% | +14.90% | -10.23% | +0.79% | -1.64% | +13.98% | +13.45% | +3.33% | +7.59% | -5.88% | +18.09% | +18.60% | -13.41% | +40.81% | +31.41% | -7.20% | +35.45% | +18.75% | -6.84% | +12.37% | n/a |
| Research and Development Revenue | 15.36M | 15.49M | 15.09M | 16.39M | 14.34M | 27.92M | 21.86M | 21.83M | 22M | 21.61M | 21.19M | 28.36M | 25.55M | 21.85M | 21.99M | 22.66M | 18.75M | 16.37M | 15.31M | 13.46M | 13.39M | 12.73M | 13.45M | 12.24M | 11.72M |
| Research and Development Revenue Growth | -0.88% | +2.69% | -7.93% | +14.32% | -48.66% | +27.72% | +0.14% | -0.76% | +1.82% | +1.96% | -25.29% | +11.00% | +16.97% | -0.65% | -2.94% | +20.81% | +14.53% | +6.96% | +13.76% | +0.46% | +5.21% | -5.32% | +9.89% | +4.42% | n/a |